Cross-source identifiers
Every current identifier attachment, with the link method and confidence carried verbatim — deterministic links are 1.000; probabilistic links surface their real matcher confidence, never rounded up.
| Scheme | Value | Source table | Link method | Confidence | Since | Provenance |
|---|---|---|---|---|---|---|
| cms_op_profile_id | 11273670 | cms_open_payments | exact_npi_in_open_payments | 1.000 | 2026-06-13 | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 evidence: {"npi":"1477138832","rule":"D-OP-NPI","recipient_profile_id":"11273670"} |
| npi | 1477138832 | nppes_providers | deterministic_pk | 1.000 | 2026-06-11 | evidencerecorded: 2026-06-11 methodology: entity-graph/v1 evidence: {"rule":"D-NPI","source_pk":"1477138832","entity_type_code":"1"} |
| pac_id | 6709274343 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-15 | evidencerecorded: 2026-06-15 methodology: entity-graph/v1 evidence: {"npi":"1477138832","rule":"D-PECOS","enrlmt_id":"I20211101000731","pecos_asct_cntl_id":"6709274343"} |
| pecos_enrlmt_id | I20211101000731 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-15 | evidencerecorded: 2026-06-15 methodology: entity-graph/v1 evidence: {"npi":"1477138832","rule":"D-PECOS","enrlmt_id":"I20211101000731"} |
| pecos_enrlmt_id | I20221012002972 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1477138832","rule":"D-PECOS","enrlmt_id":"I20221012002972"} |
| pecos_enrlmt_id | I20240724000277 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1477138832","rule":"D-PECOS","enrlmt_id":"I20240724000277"} |
Graph edges
One-hop relationships — ownership, chain membership, operation — each backed by a federal source row.
| Relationship | Entity | Confidence | Source table | Provenance |
|---|---|---|---|---|
| ← pays | Novartis Pharmaceuticals Corporation (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000228","nature_of_payment":"Food and Beverage"} |
| ← pays | ANI Pharmaceuticals, Inc. (MN) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000971883","nature_of_payment":"Food and Beverage"} |
| ← pays | Ipsen Biopharmaceuticals, Inc (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000123","nature_of_payment":"Food and Beverage"} |
| ← pays | Alexion Pharmaceuticals, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000005462","nature_of_payment":"Food and Beverage"} |
| ← pays | Celgene Corporation (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000343","nature_of_payment":"Food and Beverage"} |
| ← pays | E.R. Squibb & Sons, L.L.C. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000005499","nature_of_payment":"Food and Beverage"} |
| ← pays | Biogen, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000193","nature_of_payment":"Food and Beverage"} |
| ← pays | AstraZeneca Pharmaceuticals LP (DE) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000146","nature_of_payment":"Food and Beverage"} |
| ← pays | ABBVIE INC. (IL) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000204","nature_of_payment":"Food and Beverage"} |
| ← pays | Boehringer Ingelheim Pharmaceuticals, Inc. (CT) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000234","nature_of_payment":"Food and Beverage"} |
| ← pays | EMD Serono, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000127","nature_of_payment":"Food and Beverage"} |
| ← pays | Grifols USA, LLC (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000005420","nature_of_payment":"Food and Beverage"} |
| ← pays | PFIZER INC. (NY) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000286","nature_of_payment":"Food and Beverage"} |
| ← pays | Genentech USA, Inc. (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000226","nature_of_payment":"Food and Beverage"} |
| ← pays | Genentech, Inc. (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000089","nature_of_payment":"Food and Beverage"} |
| ← pays | CSL Behring (PA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000005563","nature_of_payment":"Food and Beverage"} |
| ← pays | Lilly USA, LLC (IN) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000066","nature_of_payment":"Food and Beverage"} |
| ← pays | TG Therapeutics, Inc. (NC) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000961857","nature_of_payment":"Food and Beverage"} |
| ← pays | Merck Sharp & Dohme LLC (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000053","nature_of_payment":"Food and Beverage"} |
| ← pays | UCB, Inc. (GA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000000073","nature_of_payment":"Food and Beverage"} |
| ← pays | Mallinckrodt Hospital Products Inc. (MO) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000826829","nature_of_payment":"Food and Beverage"} |
| ← pays | BANNER LIFE SCIENCES, LLC (NC) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000116366","nature_of_payment":"Food and Beverage"} |
| ← pays | Axsome Therapeutics, Inc. (NY) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100001111886","nature_of_payment":"Food and Beverage"} |
| ← pays | United Therapeutics Corporation (NC) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1477138832","manufacturer_id":"100000010739","nature_of_payment":"Food and Beverage"} |
Current record
Current claims returned for this entity, grouped by provenance subject. The table exposes the source identifier recorded for each claim.
provider · 1477138832 JSON
Provider screening signals
NPI-keyed source families read directly for 1477138832: federal and state integrity lists, CMS Open Payments, Order and Referring eligibility, Medicare opt-out, and enrollment revalidation. Cells expose the source and provenance fields supplied by the selected record. A screening aid — re-confirm any match against the primary source before acting; absence means nothing on file in the data Fonteum currently holds, never a guarantee none exists.
Sanctions & integrity
Coverage staleExclusion coverage is stale or cannot be reconciled to an attested source artifact. This result is indeterminate and must not be treated as a clearance; check the current issuing-agency lists.
- Coverage status: indeterminate
- Screened 26 integrity lists; no negative determination was made.
14-tuple provenance (26)
Industry payments
On file73 CMS Open Payments records on file. Ask Fonteum for the largest payments and a cited total.
14-tuple provenance (1)
Order & referring eligibility
On fileOn the CMS Order and Referring roster — eligible to order and refer in 4 of 5 Medicare benefit categories.
- Part B: Y
- DME: Y
- HHA: Y
- PMD: Y
- Hospice: N
14-tuple provenance (1)
Medicare opt-out
None on fileNo CMS Medicare opt-out affidavit on file for this NPI.
14-tuple provenance (1)
Revalidation
On file3 Medicare enrollment records on file.
- Due date: TBD upstream — not due within the ensuing six months.
14-tuple provenance (1)
Point-in-time
Query retained claim coordinates under bitemporal-read/v1. Most facts have no superseded row; dates outside retained coverage may return no prior version, and diffs require both coordinates.
Pick a date to reconstruct, or two dates to diff. Equivalent JSON: /api/v1/history/{subject_type}/{subject_id}?at=… and …/diff?from=…&to=…